How Quest is Minimizing the Impact of Rising PPE Prices and Supply Chain Shortages
The COVID-19 pandemic has increased demand for single-use gloves and garments so dramatically, manufacturers are struggling to keep up. As we move into winter and face a surging positivity rate across the US, the gap between supply and demand will continue to grow.
The result will be higher costs driven by:
A high global demand that has tripled due to more stringent protocols in healthcare and frontline workers as well as governments stockpiling PPE across the globe.
A limited global supply due to a lack of manufacturing capabilities. Manufacturers typically produce 370 billion gloves a year, but an estimated 585 billion gloves are needed to meet global demand.
A shortage of raw materials—specifically anything made with polypropylene material—is driving up costs by 30%-50% and is expected to continue to rise.
An increase in production costs as manufacturers struggle to attract workers due to labor shortages, quarantines, and the cost of keeping workers safe. Additionally, distribution and logistics costs are increasing.
Quest Safety Products has developed a deep understanding of the pharmaceutical industry’s needs and requirements through technical training and decades of experience. This enables Quest to be hyper-focused on what impacts pharmaceutical customers at this time and source high-quality PPE alternatives during recent supply chain outages.
Learn how Quest is working to minimize the impact of rising PPE prices and supply chain shortages so you can keep your workers safe. Read more.